Latest Updates on IGC
Latest Trading on NYSEMKT
|52 Week Range||
|Avg. Volume (Weekly)||329.90K|
No data to display.
India Globalization Capital, Inc. is engaged in developing phytocannabinoid-based therapies. The company’s patent filing for the indications of pain, medical refractory epilepsy and cachexia using phytocannabinoids. It also engage in leasing, trading, developing and managing infrastructure and real estate projects. India Globalization Capital, Inc. is based in Bethesda, Maryland.